Skip to content
Search

Latest Stories

US diet company WeightWatchers files for bankruptcy

WW International logo with bold bankruptcy notice and confident recovery statement

WeightWatchers was founded in 1963

Pic credit: iStock

The famed US diet company originally known as WeightWatchers said it has filed for bankruptcy but will continue operations while its $1.15-billion debt is restructured.

The company, now known as WW International, filed for Chapter 11 bankruptcy protection that it said "will eliminate $1.15 billion in debt from the company's balance sheet, and position WeightWatchers for long-term growth and success."


"Operations continue with no impact to more than three million members worldwide for its members," it said in a statement on Tuesday.

WeightWatchers has faced mounting debt as it struggled to keep pace with competition, including weight loss drugs such as Ozempic.

The company said it "expects (the) reorganisation plan to be confirmed in approximately 40 days and to emerge as a publicly traded company."

WeightWatchers, founded in 1963, renamed itself "WW" in 2018 as it shifted to a broader marketing strategy promoting wellness beyond weight-loss programs.

More For You

Empowering women in pharmacy through self-advocacy

Amandeep Doll speaking at the RPS event 'Advocating for Yourself’

Advocate for yourself – Celebrating International Women’s Day

By Amandeep Doll

Advocating for yourself is about knowing your worth and ensuring that your voice is heard in every aspect of your professional journey.

Keep ReadingShow less
It is official: Opella is now a standalone company

Opella launches as an independent company to redefine the future of self-care.

Photo credit: gettyimages

Opella becomes standalone company as Sanofi-CD&R deal closes

Opella has officially become a standalone company, following the completion of Sanofi’s sale of a controlling 50.0% stake to private equity firm Clayton, Dubilier & Rice (CD&R).

Sanofi retains a significant shareholding with a 48.2% stake while Bpifrance holds the remaining 1.8% stake.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less